NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

Nicholson, 2003, Diagnosis and management of neuropathic pain: a balanced approach to treatment, J Am Acad Nurse Pract, 15, 3 Spruce, 2003, The pathogenesis and management of painful diabetic neuropathy: a review, Diabet Med, 20, 88, 10.1046/j.1464-5491.2003.00852.x Sindrup, 1999, Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action, Pain, 83, 389, 10.1016/S0304-3959(99)00154-2 England, 2002, Neuropathic pain, Adv Neurol, 88, 147 Jackson, 2006, Pharmacotherapy for neuropathic pain, Pain Pract, 6, 27, 10.1111/j.1533-2500.2006.00055.x Frampton, 2005, Pregabalin in the treatment of postherpetic neuralgia, Drugs, 65, 111, 10.2165/00003495-200565010-00011 Backonja, 2006, Rational multidrug therapy in the treatment of neuropathic pain, Curr Pain Headache Rep, 10, 34, 10.1007/s11916-006-0007-1 Gilron, 2005, Combination pharmacotherapy for neuropathic pain: current evidence and future directions, Expert Rev Neurother, 5, 823, 10.1586/14737175.5.6.823 Dworkin, 2007, Recommendations for the management of herpes zoster, Clin Infect Dis, 44, S1, 10.1086/510206 Wallace, 2007, Update on pharmacotherapy guidelines for treatment of neuropathic pain, Curr Pain Headache Rep, 11, 208, 10.1007/s11916-007-0192-6 de Leon-Casasola, 2007, Multimodal approaches to the management of neuropathic pain: the role of topical analgesia, J Pain Symptom Manage, 33, 356, 10.1016/j.jpainsymman.2006.11.004 Argoff, 2004, Topical treatments for pain, Curr Pain Headache Rep, 8, 261, 10.1007/s11916-004-0005-0 Sawynok, 2005, Topical analgesics in neuropathic pain, Curr Pharm Des, 11, 2995, 10.2174/1381612054865019 Bley, 2004, Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies, Expert Opin Investig Drugs, 13, 1445, 10.1517/13543784.13.11.1445 Watson, 1994, Topical capsaicin as an adjuvant analgesic, J Pain Symptom Manage, 9, 425, 10.1016/0885-3924(94)90198-8 Rains, 1997, Topical capsaicin. A review of its pharmacological properties and therapeutic potential in postherpetic neuralgia, diabetic neuropathy and osteoarthritis, Drugs Aging, 7, 317, 10.2165/00002512-199507040-00007 McCleane, 2000, Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study, Br J Clin Pharmacol, 49, 574, 10.1046/j.1365-2125.2000.00200.x Mason, 2004, Systematic review of topical capsaicin for the treatment of chronic pain, BMJ, 328, 991, 10.1136/bmj.38042.506748.EE Simpson, 2008, A trial of a high-concentration capsaicin patch for the treatment of painful HIV neuropathy, Neurology, 70, 2305, 10.1212/01.wnl.0000314647.35825.9c Simpson, 2008, An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy, J Pain Symptom Manage, 35, 299, 10.1016/j.jpainsymman.2007.04.015 Backonja, 2004, One-hour high-concentration capsaicin provide durable pain relief in initial and repeated treatment of post-herpetic neuralgia (PHN). American Academy of Neurology Annual Meeting, Neurology, 62, A441 Farrar, 2001, Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale, Pain, 94, 149, 10.1016/S0304-3959(01)00349-9 1999 Medical Dictionary for Regulatory Activities Terminology (MedDRA), Version 8.0. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Reston, VA: MedDRA MSSO, March 1, 2005. Nolano, 1999, Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation, Pain, 81, 135, 10.1016/S0304-3959(99)00007-X